Quanterix Corp (QTRX) - Total Liabilities
Based on the latest financial reports, Quanterix Corp (QTRX) has total liabilities worth $129.61 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Quanterix Corp - Total Liabilities Trend (2015–2024)
This chart illustrates how Quanterix Corp's total liabilities have evolved over time, based on quarterly financial data. See QTRX working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Quanterix Corp Competitors by Total Liabilities
The table below lists competitors of Quanterix Corp ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
S.Kijchai Enterprise Public Company Limited
BK:SKN
|
Thailand | ฿1.62 Billion |
|
Guardian Capital Group Limited
TO:GCG
|
Canada | CA$748.64 Million |
|
GDB Holdings Bhd
KLSE:0198
|
Malaysia | RM212.23 Million |
|
Evertop Wire Cable Corp
TW:1616
|
Taiwan | NT$2.06 Billion |
|
Mayne Pharma Group Ltd
AU:MYX
|
Australia | AU$644.32 Million |
|
1911 Gold Corp
V:AUMB
|
Canada | CA$9.87 Million |
|
Laramide Resources Ltd
AU:LAM
|
Australia | AU$5.94 Million |
|
Genesis Land Development Corp.
TO:GDC
|
Canada | CA$297.77 Million |
Liability Composition Analysis (2015–2024)
This chart breaks down Quanterix Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Quanterix Corp.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.02 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.41 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.29 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Quanterix Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Quanterix Corp (2015–2024)
The table below shows the annual total liabilities of Quanterix Corp from 2015 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $76.50 Million | -2.69% |
| 2023-12-31 | $78.61 Million | +3.91% |
| 2022-12-31 | $75.65 Million | +15.39% |
| 2021-12-31 | $65.56 Million | +0.99% |
| 2020-12-31 | $64.92 Million | +57.22% |
| 2019-12-31 | $41.29 Million | +58.38% |
| 2018-12-31 | $26.07 Million | +0.61% |
| 2017-12-31 | $25.91 Million | +9.61% |
| 2016-12-31 | $23.64 Million | +4.86% |
| 2015-12-31 | $22.55 Million | -- |
About Quanterix Corp
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa … Read more